EP1206470A2 - Methodes efficaces de preparation d'inhibiteurs de protease de rhinovirus, intermediaires cles et reacteur a membrane continue utile dans leur preparation - Google Patents

Methodes efficaces de preparation d'inhibiteurs de protease de rhinovirus, intermediaires cles et reacteur a membrane continue utile dans leur preparation

Info

Publication number
EP1206470A2
EP1206470A2 EP00955830A EP00955830A EP1206470A2 EP 1206470 A2 EP1206470 A2 EP 1206470A2 EP 00955830 A EP00955830 A EP 00955830A EP 00955830 A EP00955830 A EP 00955830A EP 1206470 A2 EP1206470 A2 EP 1206470A2
Authority
EP
European Patent Office
Prior art keywords
formula
compound
group
process according
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00955830A
Other languages
German (de)
English (en)
Inventor
Junhua Tao
Srinivasan Babu
Raymond Dagnino, Jr.
Qingping Tian
Travis Paul Remarchuk
Kevin Scott Mcgee
Naresh K. Nayyar
Terence Jarold Moran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agouron Pharmaceuticals LLC
Original Assignee
Agouron Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals LLC filed Critical Agouron Pharmaceuticals LLC
Publication of EP1206470A2 publication Critical patent/EP1206470A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/2415—Tubular reactors
    • B01J19/2435—Loop-type reactors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/2475—Membrane reactors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00002—Chemical plants
    • B01J2219/00027—Process aspects
    • B01J2219/00033—Continuous processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
    • B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
    • B01J2219/00099—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor the reactor being immersed in the heat exchange medium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
    • B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
    • B01J2219/00103—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor in a heat exchanger separate from the reactor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00159—Controlling the temperature controlling multiple zones along the direction of flow, e.g. pre-heating and after-cooling
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00162—Controlling or regulating processes controlling the pressure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00177—Controlling or regulating processes controlling the pH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne des voies de synthèse efficaces dans la préparation d'inhibiteurs de protéase de rhinovirus de la formule (I), des intermédiaires clés utiles dans ces voies de synthèse, ainsi qu'un réacteur à membrane continue utile pour ces voies de synthèse. Ces composés de la formule (I), de même que des compositions pharmaceutiques contenant ces composés, sont adaptés au traitement de patients ou hôtes infectés par un ou plusieurs picornavirus.
EP00955830A 1999-08-24 2000-08-23 Methodes efficaces de preparation d'inhibiteurs de protease de rhinovirus, intermediaires cles et reacteur a membrane continue utile dans leur preparation Withdrawn EP1206470A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15036599P 1999-08-24 1999-08-24
US150365P 1999-08-24
PCT/US2000/023032 WO2001014576A2 (fr) 1999-08-24 2000-08-23 Methodes efficaces de preparation d'inhibiteurs de protease de rhinovirus, intermediaires cles et reacteur a membrane continue utile dans leur preparation

Publications (1)

Publication Number Publication Date
EP1206470A2 true EP1206470A2 (fr) 2002-05-22

Family

ID=22534191

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00955830A Withdrawn EP1206470A2 (fr) 1999-08-24 2000-08-23 Methodes efficaces de preparation d'inhibiteurs de protease de rhinovirus, intermediaires cles et reacteur a membrane continue utile dans leur preparation

Country Status (15)

Country Link
EP (1) EP1206470A2 (fr)
JP (1) JP2003511350A (fr)
KR (1) KR20020030795A (fr)
CN (2) CN1524960A (fr)
AU (1) AU778062B2 (fr)
BR (1) BR0013323A (fr)
CA (1) CA2376509A1 (fr)
CZ (1) CZ2002634A3 (fr)
HK (1) HK1051363A1 (fr)
HU (1) HUP0203315A3 (fr)
IL (1) IL147862A0 (fr)
MX (1) MXPA02001947A (fr)
PL (1) PL357162A1 (fr)
WO (1) WO2001014576A2 (fr)
ZA (1) ZA200200506B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0400624A2 (hu) 1998-04-30 2004-06-28 Agouron Pharmaceuticals, Inc. Picornavírus-ellenes vegyületek, előállításuk és alkalmazásuk
CN1372566A (zh) 1999-08-04 2002-10-02 阿格罗尼制药公司 抗细小核糖核酸病毒的化合物和组合物,它们的药物用途,及其合成原料
US6774243B2 (en) 1999-08-24 2004-08-10 Agouron Pharmaceuticals, Inc. Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
PA8507801A1 (es) 1999-12-03 2002-08-26 Agouron Pharma Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
PE20011277A1 (es) 2000-04-14 2002-01-07 Agouron Pharma Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
MXPA02012456A (es) 2000-06-14 2004-01-26 Agouron Pharma Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y materiales para su sintesis.
DE10208007A1 (de) * 2002-02-26 2003-09-18 Forschungszentrum Juelich Gmbh Verfahren zur Herstellung von Alkoholen aus Substraten mittels Oxidoreduktasen, Zweiphasensystem umfassend eine wässrige Phase und eine organische Phase sowie Vorrichtung zur Durchführung des Verfahrens
CN106831657B (zh) * 2017-02-23 2019-07-16 江苏工程职业技术学院 一种环氧丙酸钾的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2426651C3 (de) * 1974-06-01 1982-04-08 Bayer Ag, 5090 Leverkusen (-)-Antipode des 3-(p-Chlorphenyl)-2-chlorpropionsäuremethylesters, Verfahren zu dessen Herstellung sowie dessen Verwendung als Herbizid
DE2930087A1 (de) * 1979-07-25 1981-02-26 Biotechnolog Forschung Gmbh Verfahren zur kontinuierlichen enzymatischen umwandlung von wasserloeslichen alpha -ketocarbonsaeuren in die entsprechenden alpha -hydroxycarbonsaeuren
JPH0623131B2 (ja) * 1984-08-07 1994-03-30 三井東圧化学株式会社 α−ケト酸のアルカリ金属塩の製造法
JPH066539B2 (ja) * 1986-03-14 1994-01-26 三共株式会社 α−ハイドロキシカルボン酸誘導体の製法
FR2686897B1 (fr) * 1992-02-05 1995-07-13 Sonertec Procede en continu de fabrication d'acides organiques.
US5360927A (en) * 1994-01-24 1994-11-01 Development Center For Biotechnology Process for the preparation of monohydrated sodium phenylpyruvate
US5869697A (en) * 1994-05-02 1999-02-09 Council Of Scientific & Industrial Research Process for preparing diltiazem

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0114576A2 *

Also Published As

Publication number Publication date
WO2001014576A8 (fr) 2002-06-20
HK1051363A1 (en) 2003-08-01
CN1157391C (zh) 2004-07-14
PL357162A1 (en) 2004-07-26
HUP0203315A3 (en) 2003-12-29
KR20020030795A (ko) 2002-04-25
CZ2002634A3 (cs) 2002-09-11
AU6797000A (en) 2001-03-19
WO2001014576B1 (fr) 2001-09-27
IL147862A0 (en) 2002-08-14
WO2001014576A2 (fr) 2001-03-01
CA2376509A1 (fr) 2001-03-01
MXPA02001947A (es) 2002-10-31
JP2003511350A (ja) 2003-03-25
CN1382139A (zh) 2002-11-27
ZA200200506B (en) 2003-06-25
WO2001014576A3 (fr) 2001-08-30
BR0013323A (pt) 2002-04-02
HUP0203315A2 (hu) 2003-02-28
CN1524960A (zh) 2004-09-01
AU778062B2 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
US11767292B2 (en) Process for making beta 3 agonists and intermediates
Boger et al. Total synthesis of bleomycin A2 and related agents. 2. Synthesis of (-)-Pyrimidoblamic acid, epi-(+)-Pyrimidoblamic acid,(+)-Desacetamidopyrimidoblamic acid, and (-)-Descarboxamidopyrimidoblamic acid
CN109942576B (zh) Irbinitinib及中间体的制备方法
KR102123131B1 (ko) 하이드록실화 사이클로펜타피리미딘 화합물 및 이의 염의 제조 방법
MX2015006458A (es) Sintesis de derivados de isoxazolina espirociclicos.
WO2001014576A2 (fr) Methodes efficaces de preparation d'inhibiteurs de protease de rhinovirus, intermediaires cles et reacteur a membrane continue utile dans leur preparation
CN107033161A (zh) 一种他唑巴坦酸的合成方法
KR102477924B1 (ko) 인돌 카르복스아미드 화합물을 제조하는 방법
WO2009056993A2 (fr) Procédé de synthèse de rameltéon et intermédiaires de ce dernier
AU770221B2 (en) Synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
US20030064429A1 (en) Efficient methods for the preparation of rhinovirus protease inhibitors, key intermediates and a continuous membrane reactor useful for preparing the same
CN114206847A (zh) 杂环亚基乙酰胺衍生物的制造方法
CN106632284A (zh) 泊沙康唑的制备方法
US6774243B2 (en) Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
US6355807B1 (en) Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
WO2006075888A1 (fr) Derives d'acide hydroxamique d'oxazole et leur utilisation
CN105130886A (zh) 一种4-氟-3-甲基-2-吡啶甲酸甲酯的制备方法
CN112979643B (zh) 3-(2-氯乙基)-9-羟基-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮
CN112794849B (zh) 3-(2-氯乙基)-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮的合成方法
Fokin et al. Epoxides and aziridines in click chemistry
WO2023248154A1 (fr) Procédé de préparation de chlorhydrate de viloxazine
WO2024061853A1 (fr) Sondes fluorescentes pour magl
CN114907283A (zh) 一种2-(3，5-二氯苯基)-苯并噁唑-6-羧酸的制备方法
CN115611894A (zh) 一种含氮螺环化合物或其药学上可接受的盐及其制备方法和应用
KR100697982B1 (ko) 로시글리타존의 제조방법

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020205

AX Request for extension of the european patent

Free format text: AL PAYMENT 20020205;LT PAYMENT 20020205;LV PAYMENT 20020205;MK PAYMENT 20020205;RO PAYMENT 20020205;SI PAYMENT 20020205

17Q First examination report despatched

Effective date: 20030521

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060304